Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy.
Niu YX, Xu ZX, Yu LF, Lu YP, Wang Y, Wu C, Hou YB, Li JN, Huang S, Song X, Wang X, Wang J, Li B, Guo Y, Yu Z, Zhao L, Yi DX, Wei MJ.
Niu YX, et al.
Int Immunopharmacol. 2022 Aug;109:108783. doi: 10.1016/j.intimp.2022.108783. Epub 2022 May 10.
Int Immunopharmacol. 2022.
PMID: 35561479
Review.